Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A05363 | 33281780 | Front Microbiol | Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice. | 2020 | Details |
A05364 | 33281770 | Front Microbiol | Novel Odoribacter splanchnicus Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects in vitro. | 2020 | Details |
A05365 | 33281601 | Front Pharmacol | The Target MicroRNAs and Potential Underlying Mechanisms of Yiqi-Bushen-Tiaozhi Recipe against-Non-Alcoholic Steatohepatitis. | 2020 | Details |
A05366 | 33281535 | Food Nutr Res | Bile salt hydrolase-overexpressing Lactobacillus strains can improve hepatic lipid accumulation in vitro in an NAFLD cell model. | 2020 | Details |
A05367 | 33281161 | Intern Med | Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years. | 2020 | Details |
A05372 | 33279947 | Eur J Clin Nutr | Lipid and saturated fatty acids intake and cardiovascular risk factors of obese children and adolescents. | 2020 | Details |
A05373 | 33279452 | Clin Res Hepatol Gastroenterol | Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients. | 2020 | Details |
A05374 | 33278735 | Curr Opin Pharmacol | The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
A05375 | 33278596 | Biochim Biophys Acta Mol Cell Biol Lipids | Systems biology approaches to study lipidomes in health and disease. | 2020 | Details |
A05376 | 33278029 | Pharmacotherapy | Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review. | 2021 | Details |
A05377 | 33277471 | Nat Commun | XBP1 links the 12-hour clock to NAFLD and regulation of membrane fluidity and lipid homeostasis. | 2020 | Details |
A05378 | 33277283 | BMJ Open | Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis. | 2020 | Details |
A05379 | 33276220 | Adv Med Sci | Lack of change in serum sCD36 concentration in children with non-alcoholic fatty liver disease - A preliminary study. | 2020 | Details |
A05380 | 33276146 | Mol Metab | Mitochondrial oxidative function in NAFLD: Friend or foe? | 2020 | Details |
A05381 | 33275980 | Metabolism | Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression. | 2020 | Details |
A05383 | 33275637 | PLoS One | The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice. | 2020 | Details |
A05384 | 33275326 | Diabetes Obes Metab | Extended-release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials. | 2021 | Details |
A05385 | 33275239 | Eur Rev Med Pharmacol Sci | The relationship between endoplasmic reticulum stress and liver function, insulin resistance and vascular endothelial function in patients with non-alcoholic fatty liver disease. | 2020 | Details |
A05386 | 33275161 | Diabetologia | The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels. | 2020 | Details |
A05388 | 33273997 | Oxid Med Cell Longev | Plant Sterol Ester of α-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial Biogenesis. | 2019 | Details |
A05389 | 33273916 | Int J Endocrinol | Follicle-Stimulating Hormone Positively Associates with Metabolic Factors in Perimenopausal Women. | 2020 | Details |
A05390 | 33273703 | Sci Rep | Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study. | 2020 | Details |
A05391 | 33273527 | Sci Rep | Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH. | 2020 | Details |
A05392 | 33272889 | Clin Res Hepatol Gastroenterol | Vitamin E in paediatric non-alcoholic fatty liver disease: a meta-analysis. | 2020 | Details |
A05393 | 33272734 | Gastroenterol Hepatol | Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway. | 2020 | Details |
A05394 | 33272125 | Stroke | Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events. | 2020 | Details |
A05395 | 33271878 | Cells | Modeling Non-Alcoholic Fatty Liver Disease (NAFLD) Using "Good-Fit" Genome-Editing Tools. | 2020 | Details |
A05396 | 33271781 | Int J Mol Sci | Two-Week Isocaloric Time-Restricted Feeding Decreases Liver Inflammation without Significant Weight Loss in Obese Mice with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
A05397 | 33271332 | Mol Metab | Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis. | 2020 | Details |
A05398 | 33271299 | Complement Ther Med | Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
A05399 | 33270924 | J Bone Miner Res | Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models. | 2020 | Details |
A05400 | 33270482 | Expert Rev Gastroenterol Hepatol | A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. | 2020 | Details |
A05401 | 33269568 | Minerva Endocrinol | The triglyceride glucose index (TyG) and CDKAL1 gene rs10946398 SNP are associated with NAFLD in Chinese adults. | 2020 | Details |
A05402 | 33269500 | J Gastroenterol Hepatol | Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
A05403 | 33269420 | Hepatol Int | Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease. | 2020 | Details |
A05404 | 33269259 | World J Clin Cases | Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis. | 2020 | Details |
A05405 | 33269229 | Quant Imaging Med Surg | Collagen deposition in the liver is strongly and positively associated with T1rho elongation while fat deposition is associated with T1rho shortening: an experimental study of methionine and choline-deficient (MCD) diet rat model. | 2020 | Details |
A05406 | 33269025 | J Med Biochem | Is endocan a novel potential biomarker of liver steatosis and fibrosis? | 2020 | Details |
A05407 | 33269017 | J Med Biochem | Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis. | 2020 | Details |
A05408 | 33268953 | World J Gastroenterol | Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. | 2020 | Details |
A05409 | 33268944 | World J Gastroenterol | Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. | 2020 | Details |
A05410 | 33268887 | Cell Mol Immunol | Immunological mechanisms and therapeutic targets of fatty liver diseases. | 2020 | Details |
A05411 | 33268842 | Lab Invest | Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin. | 2020 | Details |
A05412 | 33268673 | Biomed Res | Plasma lipoprotein profile from nonalcoholic steatohepatitis model rats. | 2020 | Details |
A05413 | 33268509 | Sci Transl Med | Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. | 2020 | Details |
A05414 | 33268508 | Sci Transl Med | Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome. | 2020 | Details |
A05415 | 33268450 | BMJ Open Diabetes Res Care | SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews. | 2020 | Details |
A05416 | 33268331 | Biol Open | iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery. | 2020 | Details |
A05417 | 33268036 | Clin Res Hepatol Gastroenterol | Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease. | 2020 | Details |
A05419 | 33266488 | Int J Mol Sci | Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P. | 2020 | Details |
A05420 | 33266321 | Cells | Comparative Transcriptomics Analyses in Livers of Mice, Humans, and Humanized Mice Define Human-Specific Gene Networks. | 2020 | Details |
A05421 | 33264665 | J Nutr Biochem | Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet. | 2020 | Details |
A05422 | 33263565 | J Endocrinol | Overexpression of the Lias gene attenuates hepatic steatosis in Leprdb/db mice. | 2021 | Details |
A05423 | 33262120 | Diabetes | A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo. | 2020 | Details |
A05424 | 33261113 | Biomedicines | Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis. | 2020 | Details |
A05425 | 33261044 | Int J Mol Sci | Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver. | 2020 | Details |
A05426 | 33260679 | Nutrients | The Dietary Replacement of Soybean Oil by Canola Oil Does Not Prevent Liver Fatty Acid Accumulation and Liver Inflammation in Mice. | 2020 | Details |
A05427 | 33260590 | Int J Mol Sci | Maternal Malnutrition Affects Hepatic Metabolism through Decreased Hepatic Taurine Levels and Changes in HNF4A Methylation. | 2020 | Details |
A05428 | 33260451 | Int J Mol Sci | Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity. | 2020 | Details |
A05429 | 33260239 | Horm Metab Res | The Role of Brown Adipose Tissue in the Development and Treatment of Nonalcoholic Steatohepatitis: An Exploratory Gene Expression Study in Mice. | 2020 | Details |
A05430 | 33259845 | J Hepatol | Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus. | 2020 | Details |
A05431 | 33259835 | Metabolism | The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
A05432 | 33259744 | Metab Syndr Relat Disord | Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity. | 2020 | Details |
A05433 | 33259137 | Liver Transpl | Histidine-Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis. | 2021 | Details |
A05434 | 33257903 | Int J Endocrinol Metab | Effects of Vitamin D Supplementation in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
A05435 | 33257853 | Nat Biomed Eng | A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis. | 2020 | Details |
A05438 | 33257471 | Gut | Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. | 2020 | Details |
A05439 | 33256275 | Zhonghua Gan Zang Bing Za Zhi | [Introduction to the APASL clinical guidelines on the management of metabolic-associated fatty liver disease]. | 2020 | Details |
A05440 | 33256232 | J Clin Med | Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk. | 2020 | Details |
A05441 | 33255949 | Biology (Basel) | Why Hepatic CYP2E1-Elevation by Itself Is Insufficient for Inciting NAFLD/NASH: Inferences from Two Genetic Knockout Mouse Models. | 2020 | Details |
A05442 | 33255560 | Diagnostics (Basel) | Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
A05443 | 33255404 | Nutrients | POCU1b, the n-Butanol Soluble Fraction of Polygoni Cuspidati Rhizoma et Radix, Attenuates Obesity, Non-Alcoholic Fatty Liver, and Insulin Resistance via Inhibitions of Pancreatic Lipase, cAMP-Dependent PDE Activity, AMPK Activation, and SOCS-3 Suppression. | 2020 | Details |
A05444 | 33255318 | Int J Mol Sci | The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma. | 2020 | Details |
A05445 | 33254688 | Environ Pollut | Autophagy mediates perfluorooctanoic acid-induced lipid metabolism disorder and NLRP3 inflammasome activation in hepatocytes. | 2020 | Details |
A05446 | 33253736 | Int J Cardiol | Sudden cardiac death following liver transplantation: Incidence, trends and risk predictors. | 2020 | Details |
A05447 | 33253604 | Pharm Biol | Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease. | 2020 | Details |
A05449 | 33253343 | Yonago Acta Med | Erratum for Ikeda et al., "Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease". | 2020 | Details |
A05450 | 33252713 | Protein Cell | Targeting the alternative bile acid synthetic pathway for metabolic diseases. | 2020 | Details |
A05451 | 33252454 | Am J Gastroenterol | A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients. | 2021 | Details |
A05452 | 33251981 | Acta Chir Belg | Combined liver transplantation and off-pump coronary artery bypass grafting: a report of two cases. | 2020 | Details |
A05453 | 33251225 | Front Med (Lausanne) | Adiponectin Inhibits NLRP3 Inflammasome Activation in Nonalcoholic Steatohepatitis via AMPK-JNK/ErK1/2-NFκB/ROS Signaling Pathways. | 2020 | Details |
A05454 | 33251056 | Cureus | Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver Disease. | 2020 | Details |
A05455 | 33250371 | Nutr Metab Cardiovasc Dis | Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD. | 2020 | Details |
A05456 | 33250172 | J Pediatr | The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus. | 2020 | Details |
A05457 | 33249742 | Mol Nutr Food Res | Catechin-Rich Green Tea Extract and the Loss-of-TLR4 Signaling Differentially Alter the Hepatic Metabolome in Mice with Nonalcoholic Steatohepatitis. | 2020 | Details |
A05459 | 33249617 | J Clin Lab Anal | Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity. | 2020 | Details |
A05461 | 33248976 | Arab J Gastroenterol | Association of obesity and non-alcoholic fatty liver disease with the fecal calprotectin level in children. | 2020 | Details |
A05462 | 33248947 | Arch Biochem Biophys | The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD. | 2020 | Details |
A05463 | 33248441 | J Clin Endocrinol Metab | Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery. | 2021 | Details |
A05464 | 33248170 | J Hepatol | Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. | 2020 | Details |
A05465 | 33248168 | J Hepatol | Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance. | 2020 | Details |
A05470 | 33248065 | Metabolism | Functions of amyloid precursor protein in metabolic diseases. | 2020 | Details |
A05471 | 33247011 | BMJ Open | Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China. | 2020 | Details |
A05472 | 33246954 | Sci Adv | CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression. | 2020 | Details |
A05473 | 33246225 | Biomed Pharmacother | Akkermansia muciniphila: A potential novel mechanism of nuciferine to improve hyperlipidemia. | 2020 | Details |
A05474 | 33246008 | Metabolism | Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus. | 2020 | Details |
A05475 | 33244884 | J Cachexia Sarcopenia Muscle | Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models. | 2020 | Details |
A05476 | 33244871 | J Diabetes Investig | Decreased plasma n6 : n3 polyunsaturated fatty acids ratio interacting with high C-peptide promotes non-alcoholic fatty liver disease in type 2 diabetes patients. | 2020 | Details |
A05477 | 33244400 | J Nutr Sci | Associations between dietary total antioxidant capacity and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study. | 2020 | Details |
A05478 | 33243135 | Endocr Metab Immune Disord Drug Targets | Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants. | 2021 | Details |